Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

executive says Drugmaker Merck , known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the year, a senior company executive said on ...

just under half of the company's sales are generated in the United States. Merck & Co: A Financial Overview Market Capitalization: Exceeding industry standards, the company's market capitalization ...

A federal judge ruled in Merck & Co.’s favor in a safety lawsuit over its Gardasil vaccine, allowing the drugmaker to sidestep more than 200 cases claiming the company concealed safety risks.

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats.

Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th. Supported by world-class markets data from Dow Jones and FactSet, and partnering with ...

One of Merck KGaA’s leading immunology assets has flunked a phase 2 lupus trial. | One of Merck KGaA’s leading immunology ...

Revenue Growth: Merck & Co's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 4.35%. This ...

The company's strategic focus on advanced technologies may also position it favorably in a volatile... Molson Coors, Merck & Co. and Deutsche Telekom are part of the Zacks Investment Ideas article.